Cyberonics Pursuing Morbid Obesity As Third NCP Indication
This article was originally published in The Gray Sheet
Executive Summary
Pilot clinical studies of Cyberonics' NCP pulse generator vagus nerve stimulation (VNS) system for the treatment of morbid obesity are likely to begin by July, President and CEO Robert Cummins announced during an October 12 teleconference.